These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23506553)

  • 21. Differential effects of nonhydroxylated flavonoids as inducers of cytochrome P450 1A and 2B isozymes in rat liver.
    Canivenc-Lavier MC; Bentejac M; Miller ML; Leclerc J; Siess MH; Latruffe N; Suschetet M
    Toxicol Appl Pharmacol; 1996 Feb; 136(2):348-53. PubMed ID: 8619243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Site-specific oxidation of flavanone and flavone by cytochrome P450 2A6 in human liver microsomes.
    Nagayoshi H; Murayama N; Kakimoto K; Takenaka S; Katahira J; Lim YR; Kim V; Kim D; Yamazaki H; Komori M; Guengerich FP; Shimada T
    Xenobiotica; 2019 Jul; 49(7):791-802. PubMed ID: 30048196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liquid chromatography-tandem mass spectrometry analysis of oxidation of 2'-, 3'-, 4'- and 6-hydroxyflavanones by human cytochrome P450 enzymes.
    Shimada T; Nagayoshi H; Murayama N; Takenaka S; Katahira J; Kim V; Kim D; Komori M; Yamazaki H; Guengerich FP
    Xenobiotica; 2021 Feb; 51(2):139-154. PubMed ID: 33047997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory monoclonal antibodies to human cytochrome P450 1A2: analysis of phenacetin O-deethylation in human liver.
    Yang TJ; Sai Y; Krausz KW; Gonzalez FJ; Gelboin HV
    Pharmacogenetics; 1998 Oct; 8(5):375-82. PubMed ID: 9825829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Theoretical quantitative structure-activity relationships of flavone ligands interacting with cytochrome P450 1A1 and 1A2 isozymes.
    Iori F; da Fonseca R; Ramos MJ; Menziani MC
    Bioorg Med Chem; 2005 Jul; 13(14):4366-74. PubMed ID: 15914008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-Function Studies of Naphthalene, Phenanthrene, Biphenyl, and Their Derivatives in Interaction with and Oxidation by Cytochromes P450 2A13 and 2A6.
    Shimada T; Takenaka S; Kakimoto K; Murayama N; Lim YR; Kim D; Foroozesh MK; Yamazaki H; Guengerich FP; Komori M
    Chem Res Toxicol; 2016 Jun; 29(6):1029-40. PubMed ID: 27137136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The inhibition by flavonoids of 2-amino-3-methylimidazo[4,5-f]quinoline metabolic activation to a mutagen: a structure-activity relationship study.
    Edenharder R; Rauscher R; Platt KL
    Mutat Res; 1997 Sep; 379(1):21-32. PubMed ID: 9330619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of human cytochrome P450 1A2 by flavones: a molecular modeling study.
    Dai R; Zhai S; Wei X; Pincus MR; Vestal RE; Friedman FK
    J Protein Chem; 1998 Oct; 17(7):643-50. PubMed ID: 9853678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular interactions between human cytochrome P450 1A2 and flavone derivatives.
    da Fonseca R; Melo A; Iori F; Menziani MC; Ramos MJ
    Med Chem; 2006 Jul; 2(4):401-6. PubMed ID: 16848753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Ligand-Based Drug Design. Discovery of 4-Trifluoromethyl-7,8-pyranocoumarin as a Selective Inhibitor of Human Cytochrome P450 1A2.
    Liu J; Pham PT; Skripnikova EV; Zheng S; Lovings LJ; Wang Y; Goyal N; Bellow SM; Mensah LM; Chatters AJ; Bratton MR; Wiese TE; Zhao M; Wang G; Foroozesh M
    J Med Chem; 2015 Aug; 58(16):6481-93. PubMed ID: 26222195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytochrome P450 family 1 inhibitors and structure-activity relationships.
    Liu J; Sridhar J; Foroozesh M
    Molecules; 2013 Nov; 18(12):14470-95. PubMed ID: 24287985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of human cytochrome P450 1B1, 1A1 and 1A2 by antigenotoxic compounds, purpurin and alizarin.
    Takahashi E; Fujita K; Kamataki T; Arimoto-Kobayashi S; Okamoto K; Negishi T
    Mutat Res; 2002 Oct; 508(1-2):147-56. PubMed ID: 12379470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids: evidence for reductive activation by cytochromes P450 1A1 and 1A2.
    Stiborová M; Frei E; Wiessler M; Schmeiser HH
    Chem Res Toxicol; 2001 Aug; 14(8):1128-37. PubMed ID: 11511187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In silico studies of polyaromatic hydrocarbon inhibitors of cytochrome P450 enzymes 1A1, 1A2, 2A6, and 2B1.
    Sridhar J; Jin P; Liu J; Foroozesh M; Stevens CL
    Chem Res Toxicol; 2010 Mar; 23(3):600-7. PubMed ID: 20078084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resveratrol is a selective human cytochrome P450 1A1 inhibitor.
    Chun YJ; Kim MY; Guengerich FP
    Biochem Biophys Res Commun; 1999 Aug; 262(1):20-4. PubMed ID: 10448061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reverse type I binding spectra of human cytochrome P450 1B1 induced by flavonoid, stilbene, pyrene, naphthalene, phenanthrene, and biphenyl derivatives that inhibit catalytic activity: a structure-function relationship study.
    Shimada T; Tanaka K; Takenaka S; Foroozesh MK; Murayama N; Yamazaki H; Guengerich FP; Komori M
    Chem Res Toxicol; 2009 Jul; 22(7):1325-33. PubMed ID: 19563207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.
    Androutsopoulos VP; Papakyriakou A; Vourloumis D; Spandidos DA
    Bioorg Med Chem; 2011 May; 19(9):2842-9. PubMed ID: 21482471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effective cytochrome P450 (CYP) inhibitor isolated from thyme (Thymus saturoides) purchased from a Japanese market.
    Brahmi Z; Niwa H; Yamasato M; Shigeto S; Kusakari Y; Sugaya K; Onose J; Abe N
    Biosci Biotechnol Biochem; 2011; 75(11):2237-9. PubMed ID: 22056445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review of Ligand Specificity Factors for CYP1A Subfamily Enzymes from Molecular Modeling Studies Reported to-Date.
    Sridhar J; Goyal N; Liu J; Foroozesh M
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28698457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro metabolism and drug interaction potential of a new highly potent anti-cytomegalovirus molecule, CMV423 (2-chloro 3-pyridine 3-yl 5,6,7,8-tetrahydroindolizine I-carboxamide).
    Bournique B; Lambert N; Boukaiba R; Martinet M
    Br J Clin Pharmacol; 2001 Jul; 52(1):53-63. PubMed ID: 11453890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.